The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Danone has acquired Functional Formularies, a provider of organic, wholefood enteral feeding formulas, from Swander Pace Capital. Based in the US, Functional Formularies develops formulas designed to provide essential nutrients and support for individuals who may have difficulty consuming solid foods due to various health conditions. Its products are crafted from organic, wholefood ingredients, avoiding artificial additives and preservatives commonly found in traditional nutritional supplements. The acquisition signals Danone's commitment to catering to the growing demand for nutritional products that prioritise health and wellness. With this acquisition, Danone aims to strengthen its position in the health and nutrition sector while providing consumers with innovative and high-quality nutritional solutions. As a pivotal component of the Renew Danone strategy, this acquisition bolsters Danone’s medical nutrition portfolio in the US, amplifying its enteral tube feeding offerings. Juergen Esser, deputy CEO and CFO at Danone, said: “As a global leader in medical nutrition, we are delighted to welcome Functional Formularies to Danone”. He added: “We are confident that with the addition of the greatly differentiated product portfolio of Functional Formularies, which complements our existing Real Food Blends branded range, we are even better positioned to support the nutritional needs of tube-fed families and patients”. Financial details were not disclosed.